Development of a blood test to screen for colorectal cancer: Which features are important? A cost-effectiveness approach

Ulrike Haug, Amy B. Knudsen & Karen M. Kuntz
Background: Adherence with colorectal cancer (CRC) screening using fecal occult blood tests (FOBTs) is low. Accordingly, researchers are actively pursuing the development of a blood test (BT) for CRC screening. Pilot studies have focused on the BT’s sensitivity for detecting invasive CRC, while[for full text, please go to the a.m. URL]